Crossmark

Comments on “The Efficacy and Safety of Botulinum Toxin Type A in Prevention of Hypertrophic Scars After Epicanthoplasty: A Split-Face Double-Blinded Randomized Controlled Trial”

Crossref DOI link: https://doi.org/10.1007/s00266-025-04847-3

Published Online: 2025-04-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qian, Chang-zhong

Wu, Jun-jie

Zhang, Zhenyu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82372412)
License Information

Text and Data Mining valid from 2025-04-04

Version of Record valid from 2025-04-04
More Information

Article History

Received: 10 February 2025

Accepted: 28 February 2025

First Online: 4 April 2025

Declarations

:

: Conflict of interest The authors declare that they have no conflict of interest to disclose. Human or Animal Rights This article does not contain any studies with human participants or animals performed by any of the authors.

: Informed Consent For this type of study, informed consent is not required.

Document is current

Any future updates will be listed below